279 related articles for article (PubMed ID: 14532267)
21. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
22. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases.
Yang L; Manithody C; Rezaie AR
Blood; 2004 Sep; 104(6):1753-9. PubMed ID: 15178583
[TBL] [Abstract][Full Text] [Related]
23. Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.
Yang L; Manithody C; Qureshi SH; Rezaie AR
Thromb Haemost; 2010 Feb; 103(2):277-83. PubMed ID: 20024502
[TBL] [Abstract][Full Text] [Related]
24. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
Nishioka J; Suzuki K
J Biol Chem; 1992 Nov; 267(31):22224-9. PubMed ID: 1331047
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
Desai UR; Petitou M; Björk I; Olson ST
J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447
[TBL] [Abstract][Full Text] [Related]
26. Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation.
Chuang YJ; Gettins PG; Olson ST
J Biol Chem; 1999 Oct; 274(40):28142-9. PubMed ID: 10497166
[TBL] [Abstract][Full Text] [Related]
27. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
28. Protease specificity and heparin binding and activation of recombinant protease nexin I.
Evans DL; McGrogan M; Scott RW; Carrell RW
J Biol Chem; 1991 Nov; 266(33):22307-12. PubMed ID: 1939253
[TBL] [Abstract][Full Text] [Related]
29. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
[TBL] [Abstract][Full Text] [Related]
30. Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin.
Rezaie AR; Yang L
Biochim Biophys Acta; 2001 Oct; 1528(2-3):167-76. PubMed ID: 11687304
[TBL] [Abstract][Full Text] [Related]
31. Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa.
Futamura A; Gettins PG
J Biol Chem; 2000 Feb; 275(6):4092-8. PubMed ID: 10660568
[TBL] [Abstract][Full Text] [Related]
32. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
Westmark PR; Tanratana P; Sheehan JP
J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
[TBL] [Abstract][Full Text] [Related]
34. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
Huntington JA; Gettins PG
Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
[TBL] [Abstract][Full Text] [Related]
35. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
Rezaie AR
Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
[TBL] [Abstract][Full Text] [Related]
36. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
Buyue Y; Misenheimer TM; Sheehan JP
J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
[TBL] [Abstract][Full Text] [Related]
37. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
Turk B; Brieditis I; Bock SC; Olson ST; Björk I
Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
[TBL] [Abstract][Full Text] [Related]
38. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Qureshi SH; Rezaie AR
J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
[TBL] [Abstract][Full Text] [Related]
39. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
40. A common protein C inhibitor exosite partially controls the heparin induced activation and inhibition of serine proteases.
Siddiqui U; Khan AB; Ahmad T; Rehman AA; Jairajpuri MA
Int J Biol Macromol; 2024 May; 266(Pt 2):131065. PubMed ID: 38521329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
